Cargando…

No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction()

BACKGROUND: The release of lipid-laden plaque material subsequent to ST-segment elevation myocardial infarction (STEMI) may contribute to the no-reflow phenomenon. The aim of this study was to investigate the association between in vivo cholesterol crystals (CCs) detected by optical coherence tomogr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katayama, Yosuke, Taruya, Akira, Kashiwagi, Manabu, Ozaki, Yuichi, Shiono, Yasutsugu, Tanimoto, Takashi, Yoshikawa, Takanori, Kondo, Toshikazu, Tanaka, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760498/ https://www.ncbi.nlm.nih.gov/pubmed/35059493 http://dx.doi.org/10.1016/j.ijcha.2022.100953

Ejemplares similares

Prognostic value of Toll-like receptor 4 on human monocyte subsets combined with computed tomography-adapted Leaman score assessing coronary artery disease
por: Ozaki, Yuichi, et al.
Publicado: (2023)

Long‐term risk stratification for hospitalized patients with acute heart failure at a single rural cardiovascular centre
por: Satogami, Keisuke, et al.
Publicado: (2023)

Diagnostic significance of paradoxical left ventricular hypertrophy in detecting cardiac amyloidosis
por: Ota, Shingo, et al.
Publicado: (2023)

Low Energy Intake Diagnosed Using the Harris–Benedict Equation Is Associated with Poor Prognosis in Elderly Heart Failure Patients
por: Taruya, Akira, et al.
Publicado: (2023)

Prevalence, Features, and Prognosis of Artery‐to‐Artery Embolic ST‐Segment–Elevation Myocardial Infarction: An Optical Coherence Tomography Study
por: Takahata, Masahiro, et al.
Publicado: (2020)

Serial changes of coronary flow reserve over one year after transcatheter aortic valve implantation in patients with severe aortic stenosis()
por: Wada, Teruaki, et al.
Publicado: (2022)

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
por: Maksimenko, Alexander V., et al.
Publicado: (2012)

“No-Reflow” Phenomenon: A Contemporary Review
por: Annibali, Gianmarco, et al.
Publicado: (2022)

Impact of cavotricuspid isthmus depth on the ablation index for successful first-pass typical atrial flutter ablation
por: Kashiwagi, Manabu, et al.
Publicado: (2021)

High-density lipoprotein cholesterol as a therapeutic target for residual risk in patients with acute coronary syndrome
por: Ozaki, Yuichi, et al.
Publicado: (2018)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

The No-reflow Phenomenon: Is it Predictable by Demographic factors and Routine Laboratory Data?
por: Namazi, Mohammadhasan, et al.
Publicado: (2021)

Coronary artery lumen complexity as a new marker for refractory symptoms in patients with vasospastic angina
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Intravascular Ultrasound Observation of the Mechanism of No-Reflow Phenomenon in Acute Myocardial Infarction
por: Li, Junxia, et al.
Publicado: (2015)

A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2022)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
por: Song, Nian-Peng, et al.
Publicado: (2020)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
por: Grancini, Luca, et al.
Publicado: (2023)

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes
por: Kaul, Sanjiv, et al.
Publicado: (2022)

No-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical Implications
por: Ahn, Seong Joon, et al.
Publicado: (2015)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2018)

A biodegradable microneedle sheet for intracorporeal topical hemostasis
por: Yokoyama, Mao, et al.
Publicado: (2020)

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012)

Delayed Treatment With Hypothermia Protects Against the No‐Reflow Phenomenon Despite Failure to Reduce Infarct Size
por: Hale, Sharon L., et al.
Publicado: (2013)

Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon
por: Qin, Tao, et al.
Publicado: (2013)

Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention
por: Abdi, Seifollah, et al.
Publicado: (2015)

hsCRP and ET-1 expressions in patients with no-reflow phenomenon after Percutaneous Coronary Intervention
por: Liu, Min, et al.
Publicado: (2017)

The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction
por: Bolayır, Hasan Ata, et al.
Publicado: (2017)

Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts
por: Hashemi-Jazi, Mohammad, et al.
Publicado: (2017)

No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient
por: Buono, Andrea, et al.
Publicado: (2019)

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD
por: Hosoda, Hayato, et al.
Publicado: (2023)

Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
por: Shemirani, Hassan, et al.
Publicado: (2014)

No-reflow phenomenon during percutaneous coronary intervention in a patient with polycythemia vera: A case report
por: Oktaviono, Yudi Her, et al.
Publicado: (2020)

Effect of Atherectomy on Lesion Preparation in Heavily Calcified Coronary Artery Disease
por: Emori, Hiroki, et al.
Publicado: (2022)

Pseudo-no-Reflow Phenomenon in Carotid Artery Stenting using FilterWire EX: Successful Recovery by Aspiration Thrombectomy
por: Han, Seung Hwan, et al.
Publicado: (2009)

Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials
por: Wang, Lan, et al.
Publicado: (2015)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study
por: Darwish, Ahmed, et al.
Publicado: (2022)

In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention
por: Liu, Fang, et al.
Publicado: (2021)

Growth Differentiation Factor 15 as a Predictor of the No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction
por: Kożuch, Marcin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tcvb3jm55p35ug168ctpmgkls1